Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

The Gothenburg MCI study: design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up.

Artikel i vetenskaplig tidskrift
Författare Anders Wallin
Arto Nordlund
Michael Jonsson
Karin Lind
Åke Edman
Mattias Göthlin
Jacob Stålhammar
Marie Eckerström
Silke Kern
Anne Börjesson-Hanson
Mårten Carlsson
Erik Olsson
Henrik Zetterberg
Kaj Blennow
Johan Svensson
Annika Öhrfelt Olsson
Maria Bjerke
Sindre Rolstad
Carl Eckerström
Publicerad i Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Volym 36
Nummer/häfte 1
Sidor 114-131
ISSN 1559-7016
Publiceringsår 2016
Publicerad vid Institutionen för neurovetenskap och fysiologi
Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi
Institutionen för medicin, avdelningen för invärtesmedicin och klinisk nutrition
Sidor 114-131
Språk en
Länkar dx.doi.org/10.1038/jcbfm.2015.147
Ämnesord Alzheimer’s disease cerebrovascular disease cognitive impairment subcortical vascular dementia white matter changes
Ämneskategorier Neurovetenskaper

Sammanfattning

There is a need for increased nosological knowledge to enable rational trials in Alzheimer's disease (AD) and related disorders. The ongoing Gothenburg mild cognitive impairment (MCI) study is an attempt to conduct longitudinal in-depth phenotyping of patients with different forms and degrees of cognitive impairment using neuropsychological, neuroimaging, and neurochemical tools. Particular attention is paid to the interplay between AD and subcortical vascular disease, the latter representing a disease entity that may cause or contribute to cognitive impairment with an effect size that may be comparable to AD. Of 664 patients enrolled between 1999 and 2013, 195 were diagnosed with subjective cognitive impairment (SCI), 274 with mild cognitive impairment (MCI), and 195 with dementia, at baseline. Of the 195 (29%) patients with dementia at baseline, 81 (42%) had AD, 27 (14%) SVD, 41 (21%) mixed type dementia (=AD+SVD=MixD), and 46 (23%) other etiologies. After 6 years, 292 SCI/MCI patients were eligible for follow-up. Of these 292, 69 (24%) had converted to dementia (29 (42%) AD, 16 (23%) SVD, 15 (22%) MixD, 9 (13%) other etiologies). The study has shown that it is possible to identify not only AD but also incipient and manifest MixD/SVD in a memory clinic setting. These conditions should be taken into account in clinical trials.Journal of Cerebral Blood Flow & Metabolism advance online publication, 15 July 2015; doi:10.1038/jcbfm.2015.147.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?